MRK

133.7200.69%
RM

Robert M. Davis

Chairman, President & CEO

Mr. Robert M. Davis, also known as Rob, J.D., is CEO and Director of Merck Sharp & Dohme LLC since July 1, 2021 and has been its Chairman since December 1, 2022. He is Chief Executive Officer and Director at Merck & Co., Inc. since July 1, 2021 and is Chairman from December 01, 2022. He serves as President at Merck & Co., Inc. since July 2021. He served as Chief Financial Officer of Merck & Co., Inc. since April 2014 until April 01, 2021. Previously, he served as Merck's President, responsible for the company's operating divisions - Human Health, Animal Health, Manufacturing and Merck Research Laboratories. Prior to that, he was Executive Vice President, Global Services and company's Chief Financial Officer. In addition, Rob is a Board Member of Project Hope, a non-profit organization focused on empowering health care workers to deliver expert care when and where it is needed most. He served as Executive Vice President of Global Services at Merck & Co. Inc. since April 2016 to April 01, 2021 and served as its Executive Vice President from April 2014 to April 2016. He is Independent Director of Duke Energy Corporation from January 08, 2018. He joined the Duke Energy Corporation on January 08, 2018. Prior to Merck, he worked for Baxter, International Inc., where he served as the Corporate Vice President and President of Medical Products from 2010 to March 2014. In that role, he oversaw a range of businesses with products used in the delivery of fluids and drugs to patients and in the treatment of end-stage kidney disease. Prior to that position, he served as Corporate Vice President and President of Baxter's renal business. He served as Baxter's Corporate Vice President and Chief Financial Officer from 2006 through 2010 and the company's Treasurer from 2004 through 2006. Prior to joining Baxter, he worked at Eli Lilly and Co., where he held numerous positions of increasing responsibility. He had served as a Director for C. R. Bard, Inc., since 2015 until 2017. He previously served on the Board of trustees for Rush University Medical Center from 2006 through 2014. He was a Director of AdvaMed from 2010 through 2014 and a Member of the Board of the Baxter International Foundation from 2006 through 2014. He was Corporate Vice President and President, Medical Products 2010-2014 and Corporate Vice President and Chief Financial Officer from 2006 to 2010, Corporate Vice President and Treasurer from 2004 to 2006 at Baxter International, Inc. Mr. Davis previously served on the Board of Directors for C. R. Bard until its merger with Becton, Dickinson and Company in December 2017. He earned his J. D. degree from Northwestern University School of Law and his MBA from Northwestern University's Kellogg Graduate School of Management, after graduating from Miami University with a bachelor's degree in finance.

Positions